Form 4: Clearwater Analytics CEO Granted 607,341 RSUs

Sentiment:

Insider Transaction Report


Clearwater Analytics Holdings, Inc. CEO Sandeep Sahai was granted 607,341 Restricted Stock Units, vesting over two years starting January 2026.

Summary

  • Sandeep Sahai, Chief Executive Officer and a Director of Clearwater Analytics Holdings, Inc. (CWAN), was granted 607,341 Restricted Stock Units (RSUs).
  • Each RSU represents a right to receive one share of the issuer's Class A Common Stock.
  • The RSUs will vest at a rate of 12.5% at the end of each 3-month period for the next 2 years, following January 1, 2026.
  • The shares underlying the RSUs will settle within thirty days of the applicable vesting date.
  • The transaction date for this grant was February 11, 2026, with an expiration date of January 1, 2035.
  • The price of the derivative security (RSU) was $0.00, which is typical for equity grants.

Sentiment

Score: 6

Explanation: StockSavvy.ai views this as a moderately positive development, primarily due to the alignment of the CEO's interests with long-term shareholder value, which is a fundamental aspect of good corporate governance.

Positives

  • The grant of Restricted Stock Units to the CEO aligns management's long-term interests with those of the shareholders, incentivizing sustained company performance.
  • Equity compensation is a standard practice for retaining and motivating key executives in publicly traded companies.

Negatives

  • The issuance of new shares upon vesting of RSUs will result in a minor dilution of existing shareholder equity, though this is a common aspect of executive compensation plans.

Risks

  • None directly identified in this filing beyond the inherent risks associated with executive compensation structures and potential future share dilution.

Future Outlook

The Restricted Stock Units are scheduled to vest quarterly over a two-year period starting January 1, 2026, with settlement occurring within thirty days of each vesting date. This outlines a clear future compensation schedule for the CEO.

Industry Context

StockSavvy.ai notes that the grant of Restricted Stock Units to a Chief Executive Officer is a common and widely accepted practice in the technology and financial services industries. This form of compensation is designed to align executive incentives with long-term shareholder value creation, a standard approach across publicly traded companies.

Comparison to Industry Standards

  • The grant of time-based Restricted Stock Units (RSUs) is a standard component of executive compensation packages across various industries, including technology and financial software.
  • The vesting schedule of 12.5% quarterly over two years is a common structure, similar to equity compensation plans observed at comparable companies like BlackRock, SS&C Technologies, and Envestnet, which also utilize multi-year vesting schedules to promote executive retention and long-term performance alignment.

Stakeholder Impact

  • Shareholders: Potential for minor dilution upon RSU vesting, but also increased alignment of CEO's interests with long-term company performance.
  • Employees (CEO): Significant equity compensation, incentivizing continued leadership and performance.

Next Steps

  • The Restricted Stock Units will begin vesting on January 1, 2026, with 12.5% vesting every three months for two years.
  • Shares will be settled and delivered to the CEO within thirty days following each vesting date.

Key Dates

DateDescription
01/01/2026Start date for the two-year vesting period of the Restricted Stock Units.
02/11/2026Date of the RSU grant transaction.
02/12/2026Date the Form 4 was signed by the attorney-in-fact for Sandeep Sahai.
01/01/2035Expiration date of the Restricted Stock Units.

Keywords

Clearwater Analytics, CWAN, Sandeep Sahai, Restricted Stock Units, RSU, Equity Grant, Executive Compensation, Insider Transaction, Form 4, Beneficial Ownership

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.